Central HIV-1 sequences are designed to reduce the distance between a vaccine reagent and diverse circulating strains, with the intent of maximizing the cross-reactive potential. The HIV RAD Team has made the first M group and B and C subtype central strains based on our design. An M group central Envelope protein is the most challenging, as it is the farthest from natural isolates and the most highly variable protein. Despite this, our first M group construct CON-6 produced a weakly viable CCR5-using pseudotyped virus; more importantly it retained important conformational attributes in terms of binding to a panel of key monoclonal antibodies, it was immunogenic, and had encouraging antigenic properties. These reagents were designed in 1999, and the global alignments can double in size regarding key subtypes, each year. Since our last submission, we have new encouraging preliminary results with a 2001 M group consensus Env called CON S, that stimulated cross-reactive neutralization responses against multiple non-B clade primary isolates. We intend to systematically explore whether further addition of the new data could improve reagent design. Also, phylogenetic theory has made recent progress, but the new methods are computationally intensive and can applied only to small data sets. We will design parallel implementations for supercomputers, to reanalyze HIV sequences with state-of-the-art methods. Preliminary data describing C subtype primary isolates indicate that isolates obtained soon after infection have distinct properties; we think it will be advantageous to concentrate on these viruses for central immunogens for vaccine design. Immune responses to the central vaccine reagents will be systematically compared to each other and to natural proteins from clades A, B and C in animal models. By comparing the breadth of response to individual antigens, both natural and central, we will ultimately be able to design a cocktail of immunogens that provides the greatest breadth; this requires first defining the response to each component.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI061734-02
Application #
7310242
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
2
Fiscal Year
2006
Total Cost
$280,038
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Pincus, Seth H; Song, Kejing; Maresh, Grace A et al. (2017) Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins. J Virol 91:
Pincus, Seth H; Song, Kejing; Maresh, Grace A et al. (2017) Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160. J Virol 91:
Go, Eden P; Liao, Hua-Xin; Alam, S Munir et al. (2013) Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins. J Proteome Res 12:1223-34
Liao, Hua-Xin; Chen, Xi; Munshaw, Supriya et al. (2011) Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med 208:2237-49
Kirchherr, Jennifer L; Hamilton, Jennifer; Lu, Xiaozhi et al. (2011) Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. Virology 409:163-74
Go, Eden P; Hewawasam, Geetha; Liao, Hua-Xin et al. (2011) Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. J Virol 85:8270-84
Barouch, Dan H; O'Brien, Kara L; Simmons, Nathaniel L et al. (2010) Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med 16:319-23
Lu, Xiaozhi; Hora, Bhavna; Cai, Fangping et al. (2010) Generation of random mutant libraries with multiple primers in a single reaction. J Virol Methods 167:146-51
Tomaras, Georgia D; Haynes, Barton F (2010) Strategies for eliciting HIV-1 inhibitory antibodies. Curr Opin HIV AIDS 5:421-7
Salazar-Gonzalez, Jesus F; Salazar, Maria G; Keele, Brandon F et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206:1273-89

Showing the most recent 10 out of 27 publications